Literature DB >> 10579273

Cerebral hemodynamic effects of phenylephrine and L-arginine after cortical impact injury.

L Cherian1, G Chacko, J C Goodman, C S Robertson.   

Abstract

OBJECTIVE: To determine the effects of a pressor agent (phenylephrine and L-arginine) on the abnormal cerebral hemodynamics and on neurologic outcome after a severe cortical impact injury in rats.
DESIGN: Prospective, randomized study.
SETTING: University laboratory.
SUBJECTS: Male Long-Evans rats, weighing 300 to 400 g, fasted overnight.
INTERVENTIONS: The animals were anesthetized with isoflurane, and a severe cortical impact injury (velocity, 5 m/sec; deformation, 3 mm) was produced in the right parietal cortex. Five minutes after impact injury, one of the following three treatments were infused: 1 mL saline intravenously for 10 mins, 300 mg/kg L-arginine in 1 mL saline intravenously for 10 mins, or 0.3 microg/kg/min phenylephrine intravenously for 3 hrs. Mean arterial pressure, intracranial pressure (ICP), cerebral perfusion pressure (CPP), and laser Doppler flow (LDF) at the impact site and in the contralateral parietal cortex were monitored for 3 hrs after the impact injury. Histologic examination of the brain was performed at 2 wks after injury in a separate group of L-arginine- and saline-treated animals.
MEASUREMENTS AND MAIN RESULTS: The immediate response to the impact injury was an increase in ICP, and a decrease in mean arterial pressure, CPP, and LDF. In the saline-treated animals, LDF decreased to <25% of the baseline values at the impact site and stayed at that level for the entire 3-hr monitoring period. On the contralateral side, LDF decreased initially and recovered gradually to approximately 50% of the preimpact baseline value. Infusion of both phenylephrine and L-arginine increased LDF back to near-baseline levels. However, phenylephrine increased ICP significantly, whereas ICP with L-arginine did not change. L-arginine treatment reduced the contusion volume from a median value of 5.28 mm3 to 0.63 mm3.
CONCLUSIONS: Phenylephrine increased cerebral blood flow (CBF) by increasing CPP. L-arginine, however, increased CBF without changing CPP. The improvement in CBF was accompanied by a decrease in neurologic injury. Although the pressor agents are used currently to increase CBF after traumatic brain injury, other strategies may also increase CBF without the potential adverse effects of induced hypertension.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10579273     DOI: 10.1097/00003246-199911000-00031

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  21 in total

1.  Vasopressor use and effect on blood pressure after severe adult traumatic brain injury.

Authors:  Pimwan Sookplung; Arunotai Siriussawakul; Amin Malakouti; Deepak Sharma; Jin Wang; Michael J Souter; Randall M Chesnut; Monica S Vavilala
Journal:  Neurocrit Care       Date:  2011-08       Impact factor: 3.210

Review 2.  Role of vasopressor administration in patients with acute neurologic injury.

Authors:  Katie M Muzevich; Stacy A Voils
Journal:  Neurocrit Care       Date:  2009-04-22       Impact factor: 3.210

3.  Hypothermia decreases cerebrospinal fluid asymmetric dimethylarginine levels in children with traumatic brain injury.

Authors:  Bhavani P Thampatty; Megan M Klamerus; Patrick J Oberly; Kerri L Feldman; Michael J Bell; Elizabeth C Tyler-Kabara; P David Adelson; Robert S B Clark; Patrick M Kochanek; Samuel M Poloyac
Journal:  Pediatr Crit Care Med       Date:  2013-05       Impact factor: 3.624

4.  Early cerebral perfusion pressure augmentation with phenylephrine after traumatic brain injury may be neuroprotective in a pediatric swine model.

Authors:  Stuart H Friess; Colin Smith; Todd J Kilbaugh; Suzanne G Frangos; Jill Ralston; Mark A Helfaer; Susan S Margulies
Journal:  Crit Care Med       Date:  2012-08       Impact factor: 7.598

5.  Significance of a reduced cerebral blood flow during the first 12 hours after traumatic brain injury.

Authors:  Roman Hlatky; Charles F Contant; Pedro Diaz-Marchan; Alex B Valadka; Claudia S Robertson
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

6.  Arginase overexpression in neurons and its effect on traumatic brain injury.

Authors:  Simran Madan; Bettina Kron; Zixue Jin; George Al Shamy; Philippe M Campeau; Qin Sun; Shan Chen; Leela Cherian; Yuqing Chen; Elda Munivez; Ming-Ming Jiang; Claudia Robertson; Clay Goodman; Rajiv R Ratan; Brendan Lee
Journal:  Mol Genet Metab       Date:  2018-07-25       Impact factor: 4.797

Review 7.  Pharmacological treatment of traumatic brain injury: a review of agents in development.

Authors:  J Hatton
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

Review 8.  Drug targets for traumatic brain injury from poly(ADP-ribose)polymerase pathway modulation.

Authors:  Valerie C Besson
Journal:  Br J Pharmacol       Date:  2009-04-09       Impact factor: 8.739

9.  The anesthetic effects on vasopressor modulation of cerebral blood flow in an immature swine model.

Authors:  Benjamin Bruins; Todd J Kilbaugh; Susan S Margulies; Stuart H Friess
Journal:  Anesth Analg       Date:  2013-03-04       Impact factor: 5.108

10.  Inhaled nitric oxide reduces secondary brain damage after traumatic brain injury in mice.

Authors:  Nicole A Terpolilli; Seong-Woong Kim; Serge C Thal; Wolfgang M Kuebler; Nikolaus Plesnila
Journal:  J Cereb Blood Flow Metab       Date:  2012-11-28       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.